| 1 |
33189717 | S-acylation status of bile acid transporter hASBT regulates its function, metabolic stability, membrane expression, and phosphorylation state. | 2021 Feb 1 |
2 |
| 2 |
34346218 | Modulatory Effect of Theaflavins on Apical Sodium-Dependent Bile Acid Transporter (ASBT) Activity. | 2021 Aug 25 |
2 |
| 3 |
32201314 | Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges. | 2020 Aug |
1 |
| 4 |
31194565 | Tyrosine Phosphorylation Regulates Plasma Membrane Expression and Stability of the Human Bile Acid Transporter ASBT (SLC10A2). | 2019 Aug 5 |
2 |
| 5 |
29198943 | Human bile acid transporter ASBT (SLC10A2) forms functional non-covalent homodimers and higher order oligomers. | 2018 Mar |
2 |
| 6 |
29304731 | Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial. | 2018 Jan 5 |
4 |
| 7 |
30129377 | Elobixibat, the first-in-class Ileal Bile Acid Transporter inhibitor, for the treatment of Chronic Idiopathic Constipation. | 2018 Aug |
1 |
| 8 |
28303230 | A novel class of apical sodium--dependent bile salt transporter inhibitors: 1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides. | 2017 Mar |
2 |
| 9 |
28336180 | An important intestinal transporter that regulates the enterohepatic circulation of bile acids and cholesterol homeostasis: The apical sodium-dependent bile acid transporter (SLC10A2/ASBT). | 2017 Oct |
6 |
| 10 |
25855079 | N-glycosylation is essential for ileal ASBT function and protection against proteases. | 2015 Jun 15 |
1 |
| 11 |
24317697 | Structural basis of the alternating-access mechanism in a bile acid transporter. | 2014 Jan 23 |
2 |
| 12 |
24498857 | Resveratrol promotes degradation of the human bile acid transporter ASBT (SLC10A2). | 2014 Apr 15 |
3 |
| 13 |
23678871 | Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes. | 2013 Jun 27 |
2 |
| 14 |
23752471 | Arylsulfonylamino-benzanilides as inhibitors of the apical sodium-dependent bile salt transporter (SLC10A2). | 2013 Jun 10 |
1 |
| 15 |
23815591 | Transmembrane domain V plays a stabilizing role in the function of human bile acid transporter SLC10A2. | 2013 Jul 30 |
2 |
| 16 |
24045943 | Transmembrane domain II of the human bile acid transporter SLC10A2 coordinates sodium translocation. | 2013 Nov 8 |
2 |
| 17 |
21646357 | Transmembrane helix 1 contributes to substrate translocation and protein stability of bile acid transporter SLC10A2. | 2011 Aug 5 |
2 |
| 18 |
21976025 | Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT. | 2011 Oct 5 |
1 |
| 19 |
18063707 | Modulation of ileal bile acid transporter (ASBT) activity by depletion of plasma membrane cholesterol: association with lipid rafts. | 2008 Feb |
8 |
| 20 |
16484503 | Cholesterol dependent downregulation of mouse and human apical sodium dependent bile acid transporter (ASBT) gene expression: molecular mechanism and physiological consequences. | 2006 Sep |
2 |
| 21 |
16541252 | The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships. | 2006 Mar |
1 |
| 22 |
15604201 | Cholesterol modulates human intestinal sodium-dependent bile acid transporter. | 2005 May |
5 |
| 23 |
16134950 | Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1). | 2005 Sep 8 |
1 |
| 24 |
15350125 | Topology scanning and putative three-dimensional structure of the extracellular binding domains of the apical sodium-dependent bile acid transporter (SLC10A2). | 2004 Sep 14 |
3 |
| 25 |
12562847 | Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB. | 2003 May |
2 |
| 26 |
12819193 | Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. | 2003 Sep 5 |
1 |
| 27 |
11808323 | [Hypolipidemic drugs--ileal Na+/bile acid cotransporter inhibitors (S-8921 etc)]. | 2002 Jan |
2 |
| 28 |
12177176 | Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94. | 2002 Aug |
1 |
| 29 |
12475240 | Identification of a region of the ileal-type sodium/bile acid cotransporter interacting with a competitive bile acid transport inhibitor. | 2002 Dec 17 |
1 |
| 30 |
9109432 | Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). | 1997 Apr 15 |
1 |